454 related articles for article (PubMed ID: 15193387)
1. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
[TBL] [Abstract][Full Text] [Related]
2. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.
Quakyi EK; Frasch CE; Buller N; Tsai CM
J Infect Dis; 1999 Sep; 180(3):747-54. PubMed ID: 10438363
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
[TBL] [Abstract][Full Text] [Related]
4. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.
Uli L; Castellanos-Serra L; Betancourt L; Domínguez F; Barberá R; Sotolongo F; Guillén G; Pajón Feyt R
Proteomics; 2006 Jun; 6(11):3389-99. PubMed ID: 16673438
[TBL] [Abstract][Full Text] [Related]
7. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
8. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
Bisaillon JG; McSween G; Portelance V; Beaudet R; Morosoli R; Pouliot P; Micusan V
Microbios; 1989; 60(244-245):193-208. PubMed ID: 2515422
[TBL] [Abstract][Full Text] [Related]
9. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.
Zhu D; Barniak V; Zhang Y; Green B; Zlotnick G
Vaccine; 2006 Jun; 24(26):5420-5. PubMed ID: 16621173
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.
Sanders H; Feavers IM
Expert Rev Vaccines; 2011 Mar; 10(3):323-34. PubMed ID: 21434800
[TBL] [Abstract][Full Text] [Related]
11. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Gorringe A; Halliwell D; Matheson M; Reddin K; Finney M; Hudson M
Vaccine; 2005 Mar; 23(17-18):2210-3. PubMed ID: 15755597
[TBL] [Abstract][Full Text] [Related]
12. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
[TBL] [Abstract][Full Text] [Related]
13. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
[TBL] [Abstract][Full Text] [Related]
14. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.
van de Waterbeemd B; Streefland M; van der Ley P; Zomer B; van Dijken H; Martens D; Wijffels R; van der Pol L
Vaccine; 2010 Jul; 28(30):4810-6. PubMed ID: 20483197
[TBL] [Abstract][Full Text] [Related]
15. Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines.
Wu T; Chen J; Murphy TF; Green BA; Gu XX
Vaccine; 2005 Oct; 23(44):5177-85. PubMed ID: 16039021
[TBL] [Abstract][Full Text] [Related]
16. Class 1/3 outer membrane protein vaccine against group B, type 15, subtype 16 meningococci.
Poolman JT; Beuvery EC; Hopman CT; Witvliet MH; Timmermans HA; Teerlink T; Zanen HC
Dev Biol Stand; 1986; 63():147-52. PubMed ID: 3091433
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba.
Ochoa-Azze RF; García-Imía L; Vérez-Bencomo V
MEDICC Rev; 2018 Jul; 20(3):22-29. PubMed ID: 31242158
[TBL] [Abstract][Full Text] [Related]
18. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
[TBL] [Abstract][Full Text] [Related]
19. Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.
Haneberg B; Dalseg R; Oftung F; Wedege E; Høiby EA; Haugen IL; Holst J; Andersen SR; Aase A; Meyer Naess L; Michaelsen TE; Namork E; Haaheim LR
Dev Biol Stand; 1998; 92():127-33. PubMed ID: 9554266
[TBL] [Abstract][Full Text] [Related]
20. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.
Milagres LG; Cristina M; Brandileone MC; Sacchi CT; Vieira VS; Zanella RC; Frasch CE
FEMS Immunol Med Microbiol; 1996 Jan; 13(1):9-17. PubMed ID: 8821393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
